BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Venous Thrombosis, Pulmonary Embolism

In brief

The purpose of this study is to learn if BMS-562247 can prevent blood clots in the legs and lungs in men and women following unilateral total knee replacement surgery. The safety of this treatment will also be studied.

Key facts

Study ID
NCT00097357
Run by
Bristol-Myers Squibb
People needed
1238
Starts
2004-10-01
Expected to finish
2005-12-01
Last updated by the study team
2010-03-02

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.